Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-27

Clinical Trial Update: Ziconotide for Non-cancer Pain by Intrathecal Administration

View source ↗

Summary

A clinical trial evaluating intrathecal ziconotide for chronic non-cancer pain is currently recruiting, sponsored by ESTEVE Pharmaceuticals SAS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziconotide (ziconotide)

Snippet

Sponsor: ESTEVE Pharmaceuticals SAS | Conditions: Pain, Chronic | Status: RECRUITING